Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $45.2 million.

  • Accendra Health's Accumulated Expenses fell 5476.99% to $45.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.2 million, marking a year-over-year decrease of 5476.99%. This contributed to the annual value of $73.7 million for FY2024, which is 3670.17% down from last year.
  • Latest data reveals that Accendra Health reported Accumulated Expenses of $45.2 million as of Q3 2025, which was down 5476.99% from $52.5 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Accumulated Expenses registered a high of $116.4 million during Q4 2023, and its lowest value of $45.2 million during Q3 2025.
  • Its 5-year average for Accumulated Expenses is $90.5 million, with a median of $96.0 million in 2022.
  • Per our database at Business Quant, Accendra Health's Accumulated Expenses surged by 7647.35% in 2021 and then tumbled by 5476.99% in 2025.
  • Quarter analysis of 5 years shows Accendra Health's Accumulated Expenses stood at $115.9 million in 2021, then fell by 19.47% to $93.3 million in 2022, then rose by 24.76% to $116.4 million in 2023, then plummeted by 36.7% to $73.7 million in 2024, then tumbled by 38.61% to $45.2 million in 2025.
  • Its Accumulated Expenses was $45.2 million in Q3 2025, compared to $52.5 million in Q2 2025 and $87.4 million in Q1 2025.